2.100
+10,53%
2026-10-16
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +55.5% | +115.4% | 3 / 3 | -43.1% | -13.09 pp | +6.92 pp | +5.4% | -2.78 | — | 16,0 | −43,1% | −4,0 | +55,5% | — | -1.15 | — |
| Pts | 8 | 12 | 12 | 0 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 2.100 (close price on 2026-10-16)EPS (TTM): −322,1
Financial charts
1.Revenue & growth
VND bn16,0Q3/26
1.Revenue & growth
VND bn16,0Q3/26
2.Profit & growth
VND bn-3,97Q3/26
3.Profit mix (Penman)
VND bn-4,86Q3/26
4.Margins & cost structure
%6.8%Q3/26
5.Returns & cash cycle
% · days1.4%Q3/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn234Q3/26
8.Funding & debt health
VND bn · times234Q3/26
9.Revenue backlog
VND bn0,00Q3/26
10.Valuation
times · %-6,5×Q3/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-263Q3/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
Share history could not be reconciled
Source: vnstockData through Q3/26